Website maintenance is scheduled for June 13-17, 2024. During this time, all ons.org content requiring login access will not be available. For help, contact help@ons.org.
This supplement to the Clinical Journal of Oncology Nursing contains the first comprehensive guidelines for managing side effects from lenalidomide, thalidomide, and bortezomib used in the treatment of multiple myeloma.